lactic acid has been researched along with rubitecan in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dadashzadeh, S; Derakhshandeh, K; Erfan, M | 1 |
| Dadashzadeh, S; Derakhshandeh, K; Saghiri, R; Soheili, M | 1 |
| Han, L; Li, R; Qing, J; Qiu, M; Ru, G; Sheng, J; Wang, J | 1 |
4 other study(ies) available for lactic acid and rubitecan
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics.
Topics: Antineoplastic Agents; Biocompatible Materials; Calorimetry, Differential Scanning; Camptothecin; Drug Compounding; Drug Delivery Systems; Lactic Acid; Microscopy, Electron, Scanning; Models, Theoretical; Molecular Structure; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Research Design; Technology, Pharmaceutical; X-Ray Diffraction | 2007 |
Preparation and in vitro characterization of 9-nitrocamptothecin-loaded long circulating nanoparticles for delivery in cancer patients.
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Camptothecin; Chromatography, High Pressure Liquid; Drug Carriers; Drug Delivery Systems; Drug Stability; Humans; In Vitro Techniques; Lactic Acid; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; X-Ray Diffraction | 2010 |
Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration.
Topics: Administration, Oral; Animals; Biological Availability; Camphanes; Camptothecin; Drug Carriers; Drug Delivery Systems; Emulsions; Intestinal Absorption; Lactic Acid; Male; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley | 2016 |